Suppr超能文献

解析蛋白磷酸酶-1 受 C 端磷酸化抑制的机制。

Towards Dissecting the Mechanism of Protein Phosphatase-1 Inhibition by Its C-Terminal Phosphorylation.

机构信息

Genome Biology Unit, European Molecular Biology Laboratory, Meyerhofstraße 1, 69117, Heidelberg, Germany.

Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Schänzlestraße 18, 79104, Freiburg, Germany.

出版信息

Chembiochem. 2021 Mar 2;22(5):834-838. doi: 10.1002/cbic.202000669. Epub 2020 Nov 17.

Abstract

Phosphoprotein phosphatase-1 (PP1) is a key player in the regulation of phospho-serine (pSer) and phospho-threonine (pThr) dephosphorylation and is involved in a large fraction of cellular signaling pathways. Aberrant activity of PP1 has been linked to many diseases, including cancer and heart failure. Besides a well-established activity control by regulatory proteins, an inhibitory function for phosphorylation (p) of a Thr residue in the C-terminal intrinsically disordered tail of PP1 has been demonstrated. The associated phenotype of cell-cycle arrest was repeatedly proposed to be due to autoinhibition of PP1 through either conformational changes or substrate competition. Here, we use PP1 variants created by mutations and protein semisynthesis to differentiate between these hypotheses. Our data support the hypothesis that pThr exerts its inhibitory function by mediating protein complex formation rather than by a direct mechanism of structural changes or substrate competition.

摘要

磷酸化酶-1(PP1)是调节磷酸丝氨酸(pSer)和磷酸苏氨酸(pThr)去磷酸化的关键因子,参与了很大一部分细胞信号通路。PP1 的异常活性与许多疾病有关,包括癌症和心力衰竭。除了通过调节蛋白进行的已确立的活性控制外,还证明了 PP1 的 C 末端固有无序尾部中的 Thr 残基的磷酸化(p)具有抑制功能。细胞周期停滞的相关表型反复被提出是由于 PP1 通过构象变化或底物竞争的自动抑制。在这里,我们使用通过突变和蛋白质半合成创建的 PP1 变体来区分这些假设。我们的数据支持这样的假设,即 pThr 通过介导蛋白质复合物形成而不是通过结构变化或底物竞争的直接机制发挥其抑制功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71b/7984433/058db8924085/CBIC-22-834-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验